Meta-Analysis for Efficacy of Etanercept for Treatment of Psoriatic Arthritis

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.1111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pms54 - Cost-Effectiveness Analysis of Etanercept as First Line of Treatment in Colombian Patients With Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparison of Two Etanercept Regimens for Treatment of Psoriasis and Psoriatic Arthritis: PRESTA Randomised Double Blind Multicentre Trial

BMJ
2010English

Anti-Tumor Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis: An Indirect Comparison Meta-Analysis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or Adalimumab

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Tofacitinib for the Treatment of Psoriasis and Psoriatic Arthritis

Expert Review of Clinical Immunology
AllergyImmunology
2018English

Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan

Advances in Therapy
MedicinePharmacology
2012English

Pulmonary Sarcoidosis After Etanercept Discontinuation in a Patient With Psoriatic Arthritis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Rheumatology and Therapy
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy